Neutraceuticals silybin B, resveratrol and epigallocatechin-3 gallate (EGCG) bind to troponin to restore the loss of lusitropy caused by cardiomyopathy mutations in vitro, in vivo, and in silico
Zeyu Yang, Alice Sheehan, Andrew E. Messer, Sharmane Tsui, Alexander J. Sparrow, Charles S Redwood, Vladimı́r Křen, Ian R. Gould, Steven Baxter Marston
Frontiers in Physiology · Dec 13, 2024Peer-reviewedBiophysics